193 related articles for article (PubMed ID: 19232014)
21. Efficacy and tolerability of prostaglandin analogs: a meta-analysis of randomized controlled clinical trials.
Aptel F; Cucherat M; Denis P
J Glaucoma; 2008 Dec; 17(8):667-73. PubMed ID: 19092464
[TBL] [Abstract][Full Text] [Related]
22. Randomized crossover study of latanoprost and travoprost in eyes with open-angle glaucoma.
Sawada A; Yamamoto T; Takatsuka N
Graefes Arch Clin Exp Ophthalmol; 2012 Jan; 250(1):123-9. PubMed ID: 21858678
[TBL] [Abstract][Full Text] [Related]
23. A randomized, prospective study of bimatoprost 0.01% or travoprost/timolol in patients previously treated with latanoprost and timolol to reduce intraocular pressure.
Nixon DR
J Ocul Pharmacol Ther; 2013 Dec; 29(10):876-81. PubMed ID: 24070367
[TBL] [Abstract][Full Text] [Related]
24. Adjunctive glaucoma therapy use associated with travoprost, bimatoprost, and latanoprost.
Covert D; Robin AL
Curr Med Res Opin; 2006 May; 22(5):971-6. PubMed ID: 16709319
[TBL] [Abstract][Full Text] [Related]
25. Effect of prophylactic intraocular pressure-lowering medication on pain during cataract surgery.
Ulaş F; Balbaba M; Çelebi S
J Ocul Pharmacol Ther; 2013 Sep; 29(7):658-62. PubMed ID: 23461283
[TBL] [Abstract][Full Text] [Related]
26. First-year treatment patterns among new initiators of topical prostaglandin analogs.
Schmier JK; Covert DW; Robin AL
Curr Med Res Opin; 2009 Apr; 25(4):851-8. PubMed ID: 19231912
[TBL] [Abstract][Full Text] [Related]
27. Central corneal thickness during treatment with travoprost 0.004% in glaucoma patients.
Schlote T; Tzamalis A; Kynigopoulos M
J Ocul Pharmacol Ther; 2009 Oct; 25(5):459-62. PubMed ID: 19857108
[TBL] [Abstract][Full Text] [Related]
28. [Impact of prostaglandin-F(2alpha)-analogues and carbonic anhydrase inhibitors on central corneal thickness -- a cross-sectional study on 403 eyes].
Viestenz A; Martus P; Schlötzer-Schrehardt U; Langenbucher A; Mardin CY
Klin Monbl Augenheilkd; 2004 Sep; 221(9):753-6. PubMed ID: 15459842
[TBL] [Abstract][Full Text] [Related]
29. Hyperemia reduction after administration of a fixed combination of bimatoprost and timolol maleate to patients on prostaglandin or prostamide monotherapy.
Paranhos A; Mendonça M; Silva MJ; Giampani J; Torres RJ; Della Paolera M; Russ H; Lottenberg CL
J Ocul Pharmacol Ther; 2010 Dec; 26(6):611-5. PubMed ID: 21029020
[TBL] [Abstract][Full Text] [Related]
30. Comment on Efficacy and tolerability of prostaglandin analogs.
Eisenberg D
J Glaucoma; 2009 Aug; 18(6):498; author reply 498-9. PubMed ID: 19593206
[No Abstract] [Full Text] [Related]
31. Additivity of bimatoprost or travoprost to latanoprost in glaucomatous monkey eyes.
Gagliuso DJ; Wang RF; Mittag TW; Podos SM
Arch Ophthalmol; 2004 Sep; 122(9):1342-7. PubMed ID: 15364714
[TBL] [Abstract][Full Text] [Related]
32. The effect of latanoprost, bimatoprost, and travoprost on circadian variation of intraocular pressure in patients with open-angle glaucoma.
Yildirim N; Sahin A; Gultekin S
J Glaucoma; 2008; 17(1):36-9. PubMed ID: 18303382
[TBL] [Abstract][Full Text] [Related]
33. The effects of prostaglandin analogues on IOP in prostanoid FP-receptor-deficient mice.
Ota T; Aihara M; Narumiya S; Araie M
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4159-63. PubMed ID: 16249494
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the effects of latanoprost, travoprost, and bimatoprost on circadian intraocular pressure in patients with glaucoma or ocular hypertension.
Orzalesi N; Rossetti L; Bottoli A; Fogagnolo P
Ophthalmology; 2006 Feb; 113(2):239-46. PubMed ID: 16458092
[TBL] [Abstract][Full Text] [Related]
35. Hyperemia-associated costs of medication changes in glaucoma patients treated initially with prostaglandin analogs.
Schwartz GF; Tan J; Kotak S
J Ocul Pharmacol Ther; 2009 Dec; 25(6):555-61. PubMed ID: 20028264
[TBL] [Abstract][Full Text] [Related]
36. Prostaglandin efficacy and safety study undertaken by race (the PRESSURE study).
Birt CM; Buys YM; Ahmed II; Trope GE;
J Glaucoma; 2010 Sep; 19(7):460-7. PubMed ID: 20051890
[TBL] [Abstract][Full Text] [Related]
37. The effect of latanoprost, bimatoprost, and travoprost on intraocular pressure after cataract surgery.
Arici MK; Erdogan H; Toker I; Vural A; Topalkara A
J Ocul Pharmacol Ther; 2006 Feb; 22(1):34-40. PubMed ID: 16503773
[TBL] [Abstract][Full Text] [Related]
38. Comparison of Travoprost and Bimatoprost plus timolol fixed combinations in open-angle glaucoma patients previously treated with latanoprost plus timolol fixed combination.
Centofanti M; Oddone F; Gandolfi S; Hommer A; Boehm A; Tanga L; Sangermani C; Sportelli V; Haustein M; Manni G; Rossetti L
Am J Ophthalmol; 2010 Oct; 150(4):575-80. PubMed ID: 20688314
[TBL] [Abstract][Full Text] [Related]
39. Feasibility and efficacy of a mass switch from latanoprost to bimatoprost in glaucoma patients in a prepaid Health Maintenance Organization.
Law SK; Song BJ; Fang E; Caprioli J
Ophthalmology; 2005 Dec; 112(12):2123-30. PubMed ID: 16225924
[TBL] [Abstract][Full Text] [Related]
40. A comparison of bimatoprost 0.03% versus the fixed-combination of latanoprost 0.005% and timolol 0.5% in adult patients with elevated intraocular pressure: an eight-week, randomized, open-label trial.
Facio AC; Reis AS; Vidal KS; de Moraes CG; Suzuki R; Hatanaka M; Susanna R
J Ocul Pharmacol Ther; 2009 Oct; 25(5):447-51. PubMed ID: 19860553
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
